NO20021732L - N-formyl peptid reseptor kompleks med et G-protein kinase signalvei modifikasjonsmiddel og fremgangsmåter for endring avsignaloverföring som fölge av stimulering med pro-inflammatoriskemidler - Google Patents
N-formyl peptid reseptor kompleks med et G-protein kinase signalvei modifikasjonsmiddel og fremgangsmåter for endring avsignaloverföring som fölge av stimulering med pro-inflammatoriskemidlerInfo
- Publication number
- NO20021732L NO20021732L NO20021732A NO20021732A NO20021732L NO 20021732 L NO20021732 L NO 20021732L NO 20021732 A NO20021732 A NO 20021732A NO 20021732 A NO20021732 A NO 20021732A NO 20021732 L NO20021732 L NO 20021732L
- Authority
- NO
- Norway
- Prior art keywords
- pro
- methods
- protein kinase
- inflammatory agents
- receptor complex
- Prior art date
Links
- 108091006027 G proteins Proteins 0.000 title 1
- 102000030782 GTP binding Human genes 0.000 title 1
- 108091000058 GTP-Binding Proteins 0.000 title 1
- 108091000080 Phosphotransferase Proteins 0.000 title 1
- 239000003795 chemical substances by application Substances 0.000 title 1
- 102100021145 fMet-Leu-Phe receptor Human genes 0.000 title 1
- 101710108492 fMet-Leu-Phe receptor Proteins 0.000 title 1
- 239000003607 modifier Substances 0.000 title 1
- 102000020233 phosphotransferase Human genes 0.000 title 1
- 230000000770 proinflammatory effect Effects 0.000 title 1
- 230000019491 signal transduction Effects 0.000 title 1
- 230000008054 signal transmission Effects 0.000 title 1
- 230000000638 stimulation Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/07—Tetrapeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
- C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/081—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Transplantation (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15967799P | 1999-10-15 | 1999-10-15 | |
| PCT/US2000/028183 WO2001029069A1 (en) | 1999-10-15 | 2000-10-12 | N-formyl peptide receptor complex with a g-protein kinase signal pathway modification agent |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20021732D0 NO20021732D0 (no) | 2002-04-12 |
| NO20021732L true NO20021732L (no) | 2002-06-12 |
Family
ID=22573520
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20021732A NO20021732L (no) | 1999-10-15 | 2002-04-12 | N-formyl peptid reseptor kompleks med et G-protein kinase signalvei modifikasjonsmiddel og fremgangsmåter for endring avsignaloverföring som fölge av stimulering med pro-inflammatoriskemidler |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP1222199A4 (pl) |
| JP (1) | JP2004507441A (pl) |
| KR (1) | KR20020057972A (pl) |
| CN (1) | CN100497374C (pl) |
| AU (1) | AU8014200A (pl) |
| BR (1) | BR0014742A (pl) |
| CA (1) | CA2387559A1 (pl) |
| CZ (1) | CZ20021342A3 (pl) |
| EA (1) | EA200200451A1 (pl) |
| HU (1) | HUP0203688A2 (pl) |
| IL (1) | IL149125A0 (pl) |
| MX (1) | MXPA02003782A (pl) |
| NO (1) | NO20021732L (pl) |
| PL (1) | PL356096A1 (pl) |
| WO (1) | WO2001029069A1 (pl) |
| ZA (1) | ZA200202937B (pl) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6844315B2 (en) | 1998-05-20 | 2005-01-18 | Erasmus Universiteit Rotterdam | Immunoregulator |
| EP1138692A1 (en) | 2000-03-29 | 2001-10-04 | Erasmus Universiteit Rotterdam | Fragments of human chorionic gonadotropin (hcg) as immunoregulator |
| US20030220258A1 (en) | 2001-12-21 | 2003-11-27 | Robbert Benner | Treatment of ischemic events |
| US8680059B2 (en) | 1998-05-20 | 2014-03-25 | Biotempt B.V. | Oligopeptide acetate and formulations thereof |
| US7358330B2 (en) | 2001-03-29 | 2008-04-15 | Biotempt B.V. | Immunoregulatory compositions |
| USRE43279E1 (en) | 2000-03-29 | 2012-03-27 | Biotemp B.V. | Compositions capable of reducing elevated blood urea concentration |
| EP1300418A1 (en) * | 2001-10-04 | 2003-04-09 | Erasmus Universiteit Rotterdam | Gene regulation by oligopeptides |
| US7786084B2 (en) | 2001-12-21 | 2010-08-31 | Biotempt B.V. | Treatment of burns |
| US7560433B2 (en) | 2001-12-21 | 2009-07-14 | Biotempt B.V. | Treatment of multiple sclerosis (MS) |
| WO2004100978A1 (en) * | 2003-05-13 | 2004-11-25 | Medvet Science Pty. Ltd. | A method of modulating cellular transmigration and agents for use therein |
| JP4846799B2 (ja) | 2005-07-05 | 2011-12-28 | バイオテンプト ベー．フェー． | 腫瘍の治療 |
| EP1864692A1 (en) | 2006-06-07 | 2007-12-12 | Biotempt B.V. | Use of peptides for the control of radiation injury |
| WO2011036308A1 (en) * | 2009-09-28 | 2011-03-31 | Theramab Gmbh | Method for preclinical testing of immunomodulatory drugs |
| CN115466306B (zh) * | 2022-01-25 | 2025-06-27 | 香港中文大学（深圳） | 一种靶向细胞膜表面甲酰肽受体的多肽、药物组合物及其应用 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR9815288A (pt) * | 1997-11-13 | 2001-02-13 | Histatek Llc | Composição farmacêutica, processos para inibir a desgranulação de mastócitos, para tratar asma em um paciente, para tratar inflamação em um paciente, para inibir a liberação de citocinas em um paciente, para inibir a liberação de histaminas em um paciente, para inibir a liberação de leucotrienos em um paciente, para reduzir a adesão, migração e agregação de linfócitos, eosinófilos e neutrófilos para um sìtio de inflamação em um paciente, para reduzir a produção de anticorpos ige no sìtio de inflamação em um paciente, para inibir a permeabilidade vascular aumentada no sìtio de inflamação em um paciente, e, para tratar inflamação crÈnica em um paciente. |
-
2000
- 2000-10-12 PL PL00356096A patent/PL356096A1/pl not_active Application Discontinuation
- 2000-10-12 KR KR1020027004714A patent/KR20020057972A/ko not_active Ceased
- 2000-10-12 CN CNB008156867A patent/CN100497374C/zh not_active Expired - Fee Related
- 2000-10-12 EA EA200200451A patent/EA200200451A1/ru unknown
- 2000-10-12 JP JP2001531867A patent/JP2004507441A/ja active Pending
- 2000-10-12 HU HU0203688A patent/HUP0203688A2/hu unknown
- 2000-10-12 CZ CZ20021342A patent/CZ20021342A3/cs unknown
- 2000-10-12 WO PCT/US2000/028183 patent/WO2001029069A1/en not_active Ceased
- 2000-10-12 EP EP00970817A patent/EP1222199A4/en not_active Withdrawn
- 2000-10-12 MX MXPA02003782A patent/MXPA02003782A/es not_active Application Discontinuation
- 2000-10-12 BR BR0014742-7A patent/BR0014742A/pt not_active IP Right Cessation
- 2000-10-12 IL IL14912500A patent/IL149125A0/xx unknown
- 2000-10-12 AU AU80142/00A patent/AU8014200A/en not_active Abandoned
- 2000-10-12 CA CA002387559A patent/CA2387559A1/en not_active Abandoned
-
2002
- 2002-04-12 NO NO20021732A patent/NO20021732L/no not_active Application Discontinuation
- 2002-04-15 ZA ZA200202937A patent/ZA200202937B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1633447A (zh) | 2005-06-29 |
| MXPA02003782A (es) | 2002-12-13 |
| BR0014742A (pt) | 2002-08-27 |
| CZ20021342A3 (cs) | 2003-01-15 |
| ZA200202937B (en) | 2003-09-23 |
| EA200200451A1 (ru) | 2002-10-31 |
| JP2004507441A (ja) | 2004-03-11 |
| CN100497374C (zh) | 2009-06-10 |
| KR20020057972A (ko) | 2002-07-12 |
| CA2387559A1 (en) | 2001-04-26 |
| AU8014200A (en) | 2001-04-30 |
| EP1222199A4 (en) | 2003-03-12 |
| WO2001029069A1 (en) | 2001-04-26 |
| IL149125A0 (en) | 2002-11-10 |
| PL356096A1 (pl) | 2004-06-14 |
| HUP0203688A2 (hu) | 2003-02-28 |
| NO20021732D0 (no) | 2002-04-12 |
| EP1222199A1 (en) | 2002-07-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20021732L (no) | N-formyl peptid reseptor kompleks med et G-protein kinase signalvei modifikasjonsmiddel og fremgangsmåter for endring avsignaloverföring som fölge av stimulering med pro-inflammatoriskemidler | |
| NO972016D0 (no) | Indolyl-Y-reseptorantagonister | |
| DK0808312T3 (da) | Indolderivater som 5-HT-receptorantagonist | |
| NO981477D0 (no) | Pyrimidinderivater som 5HT2C-reseptor antagonister | |
| CY2010003I1 (el) | Αγωνιστες των βητα-2 αδρενεργικων υποδοχεων | |
| DE69831176D1 (de) | Kappa rezeptor opioid peptide | |
| NO2006004I2 (no) | Erlotinib hydroklorid og farmasøytisk akseptable salter derav | |
| NO2008001I1 (no) | Vildagliptin og farmasoytisk akseptable salter derav | |
| DE69232072D1 (de) | Endothelin-rezeptor-antagonisten | |
| NO964955L (no) | Toveis plugganordning for bruk i en borebrönn | |
| DK1394150T3 (da) | 4-phenylpyridinderivater og deres anvendelse som NK-1-receptorantagonister | |
| DK1224175T3 (da) | Benzodiazepinderivater som metabotropiske glutamatreceptorantagonister | |
| AU5274499A (en) | Therapeutic chemokine receptor antagonists | |
| FI960953L (fi) | Endoteliinireseptoriantagonisteja | |
| ID16742A (id) | Antagonis reseptor endotelin | |
| NO2005007I1 (no) | Pemetrexed og farmasoytisk akseptable salter derav | |
| ATE258548T1 (de) | Adhäsionsrezeptor-antagonisten | |
| NO995482L (no) | Ergolinderivater og deres anvendelse som somatostatinreseptorantagonister | |
| EP0727533A3 (en) | Two-volume flushing mechanism | |
| IL148515A0 (en) | Human g-protein coupled receptor | |
| AU2001238178A1 (en) | Seven-transmembrane proteins/g-protein coupled receptors | |
| NO963331D0 (no) | 5-Heteroarylindol-derivater som benzodiazepin-reseptorsete-agonister og antagonister | |
| IL196053A0 (en) | Novel human g-protein coupled receptor | |
| DE69636597D1 (de) | Endothelin rezeptor antagonisten | |
| GB0108983D0 (en) | Molecular cloning of a 7TM receptor (AXOR34) and screening methods thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |